Please assess the completion status of the following clinical trial:

Trial Title: Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Able to understand English~* For the past 12 months, has smoked 5 or more cigarettes a day~* 18 years or older~* Planning on Quitting smoking someday~* Access to a telephone~* Willing and able to use NRT in the form of gum~* Not currently using chantix or wellbutrin~Exclusion Criteria:~* Planning to quit smoking cigarettes in the next 30 days~* Currently pregnant, breastfeeding, or planning to become pregnant in the next 12 months~* Currently using chantix or wellbutrin~* Diagnosed with an unstable heart condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Brief Advice (Type: PLACEBO_COMPARATOR): Participants will receive brief advice to quit smoking, and be provided psycho-education citing health consequences and the positive impact on mortality and morbidity.
- Motivational Interviewing (MI) (Type: EXPERIMENTAL): Motivational interviewing (MI) is a collaborative conversation style for strengthening a person's own motivation and commitment to change. MI attempts to avoid a confrontational style and, instead, guides participants toward choosing to make a change in their behavior.
- Rate Reduction (RR) (Type: EXPERIMENTAL): Participants will be informed of the strong medical evidence of systematic reductions in smoking behavior can lead to long-term smoking cessation. This condition will receive Nicotine Replacement Therapy in the form of gum.
- MI + RR (Type: EXPERIMENTAL): In this intervention, participants receive both the skills based rate reduction intervention and the more motivationally based MI intervention. This condition will receive Nicotine Replacement Therapy in the form of gum.

Based on this trial design, predict the completion outcome and termination type (if applicable).